Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis

Keyphrases

• Overexpression 100%
• Myasthenia Gravis 100%
• CXCR3 100%
• Experimental Autoimmune 42%
• MRNA Level 28%
• Acetylcholine Receptor (AChR) 28%
• Myasthenic 28%
• Myasthenia 28%
• Lymph Node Cells 28%
• Age-matched 14%
• Autoimmune Disease 14%
• T Cells 14%
• Interleukin-1β 14%
• Immune Response 14%
• Quantitative PCR 14%
• CD4+ 14%
• Experimental Autoimmune Myasthenia Gravis 14%
• Autoantigen 14%
• Mucosal Tolerance 14%
• Thymus 14%
• Chemoattractant 14%
• Immunosuppression 14%
• Effector Cells 14%
• Model Experimental 14%
• Chemokines 14%
• Effector Responses 14%
• Putative Drug Targets 14%
• CXCL9 14%
• Autoimmune 14%
• CD8+ 14%
• Microarray Technology 14%
• Monokines 14%
• CXCL10 14%
• Target Organ 14%
• Tolerance Induction 14%
• CXC Chemokines 14%
• CD19+ B Cells 14%

Immunology and Microbiology

• Myasthenia gravis 100%
• Chemokine Receptor CXCR3 100%
• CXCR3 100%
• Lymph Node Cell 40%
• Autoimmune Disease 20%
• Immune Response 20%
• Real-Time Polymerase Chain Reaction 20%
• CD4 20%
• Autoantigen 20%
• Experimental Autoimmune Myasthenia Gravis 20%
• B Cell 20%
• Effector Cell 20%
• Chemoattractant 20%
• Thymus 20%
• Immunosuppression 20%
• Upregulation 20%
• Chemokine 20%
• Tumor Necrosis Factor 20%
• CXCL10 20%
• Monokine 20%
• Target Organ 20%
• CXCL9 20%
• CD19 20%
• Interleukin-1 20%
• Alpha Chemokine 20%
• Cytotoxic T-Cell 20%